The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs for Pain Management Market Research Report 2025
Synopsis
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The global Drugs for Pain Management market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 41890 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Pain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Pain Management.
Report Scope
The Drugs for Pain Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Pain Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Pain Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Segment by Type
Generic Opioid
Branded Opioids
NSAIDs
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Pain Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The global Drugs for Pain Management market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 41890 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drugs for Pain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Pain Management.
Report Scope
The Drugs for Pain Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Pain Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Pain Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Segment by Type
Generic Opioid
Branded Opioids
NSAIDs
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Pain Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Pain Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Generic Opioid
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drugs for Pain Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Pain Management Market Perspective (2019-2030)
2.2 Drugs for Pain Management Growth Trends by Region
2.2.1 Global Drugs for Pain Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs for Pain Management Historic Market Size by Region (2019-2024)
2.2.3 Drugs for Pain Management Forecasted Market Size by Region (2025-2030)
2.3 Drugs for Pain Management Market Dynamics
2.3.1 Drugs for Pain Management Industry Trends
2.3.2 Drugs for Pain Management Market Drivers
2.3.3 Drugs for Pain Management Market Challenges
2.3.4 Drugs for Pain Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Pain Management Players by Revenue
3.1.1 Global Top Drugs for Pain Management Players by Revenue (2019-2024)
3.1.2 Global Drugs for Pain Management Revenue Market Share by Players (2019-2024)
3.2 Global Drugs for Pain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Pain Management Revenue
3.4 Global Drugs for Pain Management Market Concentration Ratio
3.4.1 Global Drugs for Pain Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Pain Management Revenue in 2023
3.5 Drugs for Pain Management Key Players Head office and Area Served
3.6 Key Players Drugs for Pain Management Product Solution and Service
3.7 Date of Enter into Drugs for Pain Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Pain Management Breakdown Data by Type
4.1 Global Drugs for Pain Management Historic Market Size by Type (2019-2024)
4.2 Global Drugs for Pain Management Forecasted Market Size by Type (2025-2030)
5 Drugs for Pain Management Breakdown Data by Application
5.1 Global Drugs for Pain Management Historic Market Size by Application (2019-2024)
5.2 Global Drugs for Pain Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drugs for Pain Management Market Size (2019-2030)
6.2 North America Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drugs for Pain Management Market Size by Country (2019-2024)
6.4 North America Drugs for Pain Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Pain Management Market Size (2019-2030)
7.2 Europe Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drugs for Pain Management Market Size by Country (2019-2024)
7.4 Europe Drugs for Pain Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Pain Management Market Size (2019-2030)
8.2 Asia-Pacific Drugs for Pain Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drugs for Pain Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Drugs for Pain Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Pain Management Market Size (2019-2030)
9.2 Latin America Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drugs for Pain Management Market Size by Country (2019-2024)
9.4 Latin America Drugs for Pain Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Pain Management Market Size (2019-2030)
10.2 Middle East & Africa Drugs for Pain Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drugs for Pain Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Drugs for Pain Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Drugs for Pain Management Introduction
11.1.4 GSK Revenue in Drugs for Pain Management Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Drugs for Pain Management Introduction
11.2.4 Pfizer Revenue in Drugs for Pain Management Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Grunenthal
11.3.1 Grunenthal Company Detail
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Drugs for Pain Management Introduction
11.3.4 Grunenthal Revenue in Drugs for Pain Management Business (2019-2024)
11.3.5 Grunenthal Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Drugs for Pain Management Introduction
11.4.4 Sanofi Revenue in Drugs for Pain Management Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Drugs for Pain Management Introduction
11.5.4 Bayer Revenue in Drugs for Pain Management Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Drugs for Pain Management Introduction
11.6.4 AstraZeneca Revenue in Drugs for Pain Management Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Detail
11.7.2 Eli Lilly Business Overview
11.7.3 Eli Lilly Drugs for Pain Management Introduction
11.7.4 Eli Lilly Revenue in Drugs for Pain Management Business (2019-2024)
11.7.5 Eli Lilly Recent Development
11.8 Endo
11.8.1 Endo Company Detail
11.8.2 Endo Business Overview
11.8.3 Endo Drugs for Pain Management Introduction
11.8.4 Endo Revenue in Drugs for Pain Management Business (2019-2024)
11.8.5 Endo Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Drugs for Pain Management Introduction
11.9.4 Merck Revenue in Drugs for Pain Management Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Yunnan Baiyao
11.10.1 Yunnan Baiyao Company Detail
11.10.2 Yunnan Baiyao Business Overview
11.10.3 Yunnan Baiyao Drugs for Pain Management Introduction
11.10.4 Yunnan Baiyao Revenue in Drugs for Pain Management Business (2019-2024)
11.10.5 Yunnan Baiyao Recent Development
11.11 Teikoku Seiyaku
11.11.1 Teikoku Seiyaku Company Detail
11.11.2 Teikoku Seiyaku Business Overview
11.11.3 Teikoku Seiyaku Drugs for Pain Management Introduction
11.11.4 Teikoku Seiyaku Revenue in Drugs for Pain Management Business (2019-2024)
11.11.5 Teikoku Seiyaku Recent Development
11.12 Teva
11.12.1 Teva Company Detail
11.12.2 Teva Business Overview
11.12.3 Teva Drugs for Pain Management Introduction
11.12.4 Teva Revenue in Drugs for Pain Management Business (2019-2024)
11.12.5 Teva Recent Development
11.13 J&J
11.13.1 J&J Company Detail
11.13.2 J&J Business Overview
11.13.3 J&J Drugs for Pain Management Introduction
11.13.4 J&J Revenue in Drugs for Pain Management Business (2019-2024)
11.13.5 J&J Recent Development
11.14 Assertio Therapeutics
11.14.1 Assertio Therapeutics Company Detail
11.14.2 Assertio Therapeutics Business Overview
11.14.3 Assertio Therapeutics Drugs for Pain Management Introduction
11.14.4 Assertio Therapeutics Revenue in Drugs for Pain Management Business (2019-2024)
11.14.5 Assertio Therapeutics Recent Development
11.15 Allergan
11.15.1 Allergan Company Detail
11.15.2 Allergan Business Overview
11.15.3 Allergan Drugs for Pain Management Introduction
11.15.4 Allergan Revenue in Drugs for Pain Management Business (2019-2024)
11.15.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
